Organization
US WorldMeds
1 clinical trial
Clinical trial
A Phase 2, Open-Label, Randomized, Controlled, Ascending Dose Cohort, Pharmacokinetic and Safety Study of Oral Lofexidine in Neonates Experiencing Opioid Withdrawal Due to Intrauterine Exposure to OpioidsStatus: Recruiting, Estimated PCD: 2024-05-01